Beijing Winsunny Pharmaceutical CO.LTD Capital Reinvestment Ratio
Beijing Winsunny Pharmaceutical CO.LTD capital reinvestment ratio. Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Capital Reinvestment Ratio of 0.57x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥690.75 Million) in capital expenditures (CN¥391.52 Million). Check how aggressively does Beijing Winsunny Pharmaceutical CO.LTD reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Capital reinvestment ratio of Beijing Winsunny Pharmaceutical CO.LTD from 2020 to 2024. This chart tracks Beijing Winsunny Pharmaceutical CO.LTD's Capital Reinvestment Ratio across 5 annual periods. Also explore 601089 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Beijing Winsunny Pharmaceutical CO.LTD Capital Reinvestment Ratio by Year (2020–2024)
Beijing Winsunny Pharmaceutical CO.LTD capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see Beijing Winsunny Pharmaceutical CO.LTD cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.57x | CN¥690.75 Million | CN¥391.52 Million | ▼ -13.9% |
| 2023 | 0.66x | CN¥555.90 Million | CN¥366.08 Million | ▲ +220.9% |
| 2022 | 0.21x | CN¥659.76 Million | CN¥135.40 Million | ▼ -43.8% |
| 2021 | 0.37x | CN¥528.02 Million | CN¥192.97 Million | ▼ -16.4% |
| 2020 | 0.44x | CN¥386.65 Million | CN¥168.96 Million | — |